Ani Pharmaceuticals (ANIP) Other financing activities (2012 - 2024)

Ani Pharmaceuticals has disclosed Other financing activities across 10 years of filings, most recently posting $2.0 million for Q4 2024.

• Other financing activities for Q4 2024 came in at $2.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.0 million (down 19.63% YoY), and the FY2024 annual result was $17.4 million, changed N/A from the prior year.
• Other financing activities came in at $2.0 million for Q4 2024 at Ani Pharmaceuticals, up from $483000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $2.0 million in Q4 2024 to a low of $3000.0 in Q1 2022.
• The 4-year median for Other financing activities is $281000.0 (2020), against an average of $603111.1.
• Across the five-year window, Other financing activities slumped 92.71% in 2020 and jumped 969.23% in 2021, its largest moves.
• Ani Pharmaceuticals' Other financing activities stood at $169000.0 in 2020, then surged by 969.23% to $1.8 million in 2021, then slumped by 73.27% to $483000.0 in 2022, then surged by 309.32% to $2.0 million in 2024.
• The last three Other financing activities figures came in at $2.0 million (Q4 2024), $483000.0 (Q3 2022), and $203000.0 (Q2 2022), per Business Quant data.